Evidence map›Paper›PMID 32737652›Full record

ArticleApoptosis : an international journal on programmed cell death2020

BAX-dependent mitochondrial pathway mediates the crosstalk between ferroptosis and apoptosis.

Young-Sun Lee, Kalishwaralal Kalimuthu, Yong Seok Park, Xu Luo, M Haroon A Choudry, David L Bartlett, Yong J Lee

Open access · greenAbstract read
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 103 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. The efficacy of hyperthermia-based multimodal therapy is dependent on gatekeeper protein, BID.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. The complexities of cell death mechanisms: a new perspective in systemic sclerosis therapy.Apoptosis : an international journal on programmed cell death · 2025
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Young-Sun LeeDepartment of Surgery, School of Medicine, University of Pittsburgh, 5117 Centre Ave, Pittsburgh, PA, 15213, USA.
Kalishwaralal KalimuthuDepartment of Surgery, School of Medicine, University of Pittsburgh, 5117 Centre Ave, Pittsburgh, PA, 15213, USA.
Yong Seok ParkDepartment of Biostatistics, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
Xu LuoEppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
M Haroon A ChoudryDepartment of Surgery, School of Medicine, University of Pittsburgh, 5117 Centre Ave, Pittsburgh, PA, 15213, USA.
David L BartlettDepartment of Surgery, School of Medicine, University of Pittsburgh, 5117 Centre Ave, Pittsburgh, PA, 15213, USA.
Yong J LeeDepartment of Surgery, School of Medicine, University of Pittsburgh, 5117 Centre Ave, Pittsburgh, PA, 15213, USA. leeyj@upmc.edu.ORCID 0000-0001-5914-8489
University of Pittsburgh · USUniversity of Nebraska Medical Center · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Mechanism of Bax/Bak Activation During ApoptosisR01GM118437 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI LUO, XU · 2017 to 2020
$1.3M
Application of a humanized patient-derived xenograft mouse model to assess the preclinical efficacy of combined chemohyperthermia and chimeric TRAIL treatment in ovarian peritoneal carcinomatosisR03CA245171 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, YONG J · 2020 to 2021
$157k
Targeted hyperthermia in combination with chimeric TRAIL and chemotherapeutic agent treatment for colorectal liver metastasisR03CA212125 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, YONG J · 2017 to 2018
$156k
Assessing the effect of anti-PD-1/PD-L1 agents on tumoricidal efficacy of secretory TRAIL-armed NK cellsR03CA205267 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, YONG J · 2017 to 2018
$155k
NCI NIH HHS P30 CA047904NCI NIH HHS R03 CA205267NCI NIH HHS R03 CA212125NCI NIH HHS R03 CA245171NIGMS NIH HHS R01 GM118437
6 · The paper itself

Abstract

Ferroptosis is considered a distinctive form of cell death compared to other types of death such as apoptosis. It is known to result from iron-dependent accumulation of lipid peroxides rather than caspase activation. However, we reported recently that ferroptosis interplays with apoptosis. In this study, we investigated a possible mechanism of this interplay between ferroptosis and apoptosis. Results from our studies reveal that combined treatment of the ferroptotic agent erastin and the apoptotic agent TRAIL effectively disrupted mitochondrial membrane potential (ΔΨm) and subsequently promoted caspase activation. The alterations of mitochondrial membrane potential are probably due to an increase in oligomerization of BAX and its accumulation at the mitochondria during treatment with erastin and TRAIL. Interestingly, the combined treatment-promoted apoptosis was effectively inhibited in BAX-deficient HCT116 cells, but not BAK-deficient cells. These results indicate that the BAX-associated mitochondria-dependent pathway plays a pivotal role in erastin-enhanced TRAIL-induced apoptosis.

Indexed as

ApoptosisApoptosis Regulatory Proteinsbcl-2-Associated X ProteinFerroptosisHCT116 CellsHumansMembrane Potential, MitochondrialMitochondriaSignal TransductionTNF-Related Apoptosis-Inducing LigandTumor Necrosis Factor-alphaApoptosis Regulatory Proteinsbcl-2-Associated X ProteinTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, humanTumor Necrosis Factor-alphaApoptosisBAXCrosstalkFerroptosisMitochondria-dependent pathway

Identifiers

PMID32737652
PMCPMC7529973
OpenAlexW3046665064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.